Altering the course of schizophrenia: progress and perspectives
Mark J Millan, Annie Andrieux, George Bartzokis, Kristin Cadenhead, Paola Dazzan, Paolo Fusar-Poli, Juergen Gallinat, Jay Giedd, Dennis R Grayson, Markus Heinrichs, Rene Kahn, Marie-Odile Krebs, Marion Leboyer, David Lewis, Oscar Marin, Philippe Marin, Andreas Meyer-Lindenberg, Patrick McGorry, Philip McGuire, Michael J Owen Show all
Nature Reviews Drug Discovery | NATURE PUBLISHING GROUP | Published : 2016
Awarded by Medical Research Council
The authors thank M. Soubeyran and J.-M. Rivet for logistical support. They would also like to thank the referees for helpful comments that strengthened the article. This paper has its origins in a small, focused meeting that took place in France in 2013, sponsored by 'Advances in Neuroscience for Medical Innovation'. Sadly, two participants at that meeting recently passed away, G. Bartzokis and P. Patterson, and the authors would like to take this opportunity to remember and pay tribute to them.